Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced an upcoming ...
During the past several weeks, there’s seemingly been lots of attention on the Choice-Select (C/S) spread. That’s not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results